Published in

Royal Society of Chemistry, Organic and Biomolecular Chemistry, 17(18), p. 3288-3296, 2020

DOI: 10.1039/c9ob02682g

Links

Tools

Export citation

Search in Google Scholar

Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Recurrence and drug resistance are major challenges in the treatment of acute myeloid leukemia (AML) that spur efforts to identify new clinical targets and active agents.